UNSPSC 51401803: Premazepam

This classification denotes a benzodiazepine with the molecular formula C15H15N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier OI7443PDLB, chemically known as 3,7-dihydro-6,7-dimethyl-5-phenylpyrrolo(3,4-e)(1,4)diazepin-2(1h)-one but generally known as premazepam, which bears US NIH Compound Identifier 72104. European Medicines Agency schedules Premazepam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10026MIG.

UNSPSC 51401803 Premazepam is a Commodity code for pharmaceutical products, though the recent state and local procurement activity tagged under it reflects a significant scope mismatch. Seminole County, Florida's July 2026 IFB for naloxone and drug deactivation systems is unrelated to premazepam, a benzodiazepine pharmaceutical with distinct clinical indications and supply-chain requirements. The code shows little relevant recent activity aligned with its nominal scope; the single tracked opportunity under this code reflects a tagging error or category misclassification rather than actual premazepam procurement by state or local bodies.

Absent evidence of recent state and local solicitations for premazepam itself, the code presents minimal current opportunity for vendors in this market segment. Business development professionals should verify whether premazepam procurement occurs under a different UNSPSC code or through alternative contracting vehicles such as state pharmaceutical cooperative purchasing programs, managed care formulary arrangements, or institutional pharmacy group purchasing organizations rather than direct competitive bidding. The mismatch between the code's pharmaceutical specificity and the naloxone opportunity tagged to it suggests procurement data quality issues that may obscure actual buying patterns under this Commodity code.